BRIEF-Vanda Pharmaceuticals Q4 EPS USD -2.39

Reuters
Feb 12
BRIEF-Vanda Pharmaceuticals Q4 EPS USD -2.39

Feb 11 (Reuters) - Vanda Pharmaceuticals Q4 operating expenses USD 97.569 million.

  • Q4 basic EPS USD -2.39
  • Q4 net income USD -141.187 million
  • Q4 operating income USD -40.353 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10